Intchains Group
ICG
SATO TECHNOLOGIES CORP
CCPUF
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
Bitfarms
BITF
US Stock MarketDetailed Quotes
MRSN Mersana Therapeutics
- 1.500
- +0.080+5.63%
Close Dec 27 16:00 ET
- 1.440
- -0.060-4.00%
Post 20:01 ET
185.30MMarket Cap-2.50P/E (TTM)
1.520High1.400Low1.34MVolume1.400Open1.420Pre Close1.95MTurnover1.72%Turnover RatioLossP/E (Static)123.53MShares6.28052wk High187.50P/B116.88MFloat Cap1.22052wk Low--Dividend TTM77.92MShs Float29.090Historical High--Div YieldTTM8.45%Amplitude0.801Historical Low1.455Avg Price1Lot Size
About Mersana Therapeutics Company
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
Company Profile
SymbolMRSN
Company NameMersana Therapeutics
Listing DateJun 28, 2017
Issue Price15.00
Founded2001
CEODr. Martin H. Huber, M.D.
MarketNASDAQ
Employees123
Fiscal Year Ends12-31
Address840 Memorial Drive
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-498-0020
Websitehttp://www.mersana.com
Company Executives
- Name
- Position
- Salary
- Dr. Martin H. Huber, M.D.
- Director, President and Chief Executive Officer
- 2.60M
- Brian DeSchuytner
- Senior Vice President, Chief Operating Officer and Chief Financial Officer
- 1.74M
- Dr. Timothy B. Lowinger, PhD
- Senior Vice President, Chief Science and Technology Officer
- 1.69M
- Mohan Bala
- Senior Vice President and Chief Development Officer
- 1.58M
- Dr. Tushar Misra, PhD
- Senior Vice President and Chief Manufacturing Officer
- --
- Alejandra Carvajal
- Senior Vice President and Chief Legal Officer
- 1.61M
- Ashish Mandelia
- Vice President, Controller and Principal Accounting Officer
- --
- David M. Mott
- Chairman of the Board
- 329.93K
- Anna Protopapas
- Director
- 4.45M
- Lawrence M. Alleva
- Independent Director
- 308.93K
- Dr. Andrew A. F. Hack, M.D.,PhD
- Independent Director
- 297.43K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 293.43K
- Dr. Willard H. Dere, M.D.
- Independent Director
- 305.43K
- Allene M. Diaz
- Independent Director
- 294.93K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.